STOCK TITAN

Syros Pharmaceut (SYRS) Free Cash Flow by Year

SYRS

Syros Pharmaceut recorded an outflow of $110.0M in free cash flow in fiscal year 2023. This represents an increase of 11.5% from the prior fiscal year. The table below carries 10 fiscal years, from 2014 to 2023, and the quarters Syros Pharmaceut has filed alongside them.

FY2023 annual
Free Cash Flow -$110.0M
YoY +11.5%
Source SEC Filings (10-K/10-Q) Latest period Q3 FY2024, ended Sep 30, 2024 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

SYRS Free Cash Flow by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricFY2310-KFY2210-KFY2110-KFY2010-KFY1910-KFY1810-KFY1710-KFY1610-KFY1510-KFY1410-K
Free Cash Flow-$110.0M+11.5%-$124.3M-23.3%-$100.8M-66.0%-$60.7M+16.7%-$72.9M-74.8%-$41.7M+8.5%-$45.5M-6.3%-$42.9M-77.1%-$24.2M-98.9%-$12.2M

SYRS Free Cash Flow by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ3'2410-QQ2'2410-QQ1'2410-QQ4'2310-QQ3'2310-QQ2'2310-QQ1'2310-QQ4'2210-KQ3'2210-QQ2'2210-QQ1'2210-QQ4'2110-K
Free Cash FlowN/AN/AN/A-$18.6M+41.4%-$31.9M+11.8%-$22.4M+14.8%-$37.1M-23.2%-$31.8M-36.8%-$36.1M-27.0%-$26.3M+2.2%-$30.1M-35.5%-$23.2M+22.5%

What free cash flow means

Free cash flow is the cash operations produced over the period, less what the company spent on property, plant and equipment, so it answers what was left over rather than what was earned on paper.

More Syros Pharmaceut financials

Frequently Asked Questions

What was Syros Pharmaceut's free cash flow in fiscal year 2023?

Syros Pharmaceut recorded an outflow of $110.0M in free cash flow in fiscal year 2023.

How fast is Syros Pharmaceut's free cash flow growing?

Syros Pharmaceut (SYRS) free cash flow rose by 11.5% year over year, from -$124.3M to -$110.0M in fiscal year 2023.

How has Syros Pharmaceut's free cash flow changed over the years?

Across the 10 fiscal years this page covers, Syros Pharmaceut (SYRS) free cash flow went from -$12.2M in fiscal year 2014 to -$110.0M in fiscal year 2023.

Free cash flow is the cash operations produced over the period, less what the company spent on property, plant and equipment, so it answers what was left over rather than what was earned on paper. This page lists what Syros Pharmaceut (SYRS) reported on that line in every period on record.